The Knights

Knight Therapeutics is a leading pan-American specialty pharmaceutical company focused on acquiring, in-licensing, and commercializing innovative pharmaceutical products for the Canadian and Latin American markets. Headquartered in Montreal, the company operates through a robust infrastructure that includes subsidiaries such as United Medical, Biotoscana Farma, and Laboratorio LKM. Knight's portfolio spans diverse therapeutic areas including oncology, hematology, infectious diseases, and women's health. The company employs a capital-efficient, deal-driven business model, leveraging strategic M&A and partnerships to bring underserved therapies to international markets. With over 800 employees, Knight maintains a significant commercial presence across more than ten countries.